SCHEMBL164856

SCHEMBL164856

CC=CC(=O)C1=C(C)C=CCC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5980820 1.00 MAOA (0.35) MAOAMAOB
SCHEMBL11448674 1.00 MAOA (0.35) MAOAMAOB
SCHEMBL5980823 1.00 MAOA (0.35) MAOAMAOB
SCHEMBL80947 1.00 MAOA (0.35) MAOAMAOB
Crotonaldehyde SCHEMBL1871907 0.91 MAOA (0.32) MAOAMAOB
SCHEMBL3643853 0.83
SCHEMBL3643855 0.83
SCHEMBL11455467 0.83 MAOA (0.33) MAOAMAOB
SCHEMBL11455469 0.83 MAOA (0.33) MAOAMAOB
SCHEMBL25201852 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION FIRMENICH & CIE (CH) 2026-03-12 US claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
EP-4405323-B1 PROCESS FOR PREPARING A CYCLIC DIENE FIRMENICH & CIE (CH) 2026-01-14 EP claimed
WO-2025202258-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-10-02 WO claimed
US-20250295826-A1 FRAGRANCES AS UREASE INHIBITORS SYMRISE AG (DE) 2025-09-25 US claimed
US-12404479-B2 Laundry detergent composition containing graft copolymer and benefit agent THE PROCTER & GAMBLE COMPANY (US) 2025-09-02 US claimed
US-20250235136-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2025-07-24 US claimed
EP-3325588-B1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2025-04-16 EP claimed
US-12251454-B2 Perfume compositions GIVAUDAN SA (CH) 2025-03-18 US claimed
US-20250034074-A1 PROCESS FOR PREPARING A CYCLIC DIENE FIRMENICH SA (CH) 2025-01-30 US claimed
WO-2000001352-A1 PERFUME COMPOSITION QUEST INTERNATIONAL B.V. (NL) 2000-01-13 WO claimed
EP-0955035-A1 Body odor preventing composition SHISEIDO COMPANY LIMITED (JP) 1999-11-10 EP claimed
EP-0596493-B1 Fragrant peracetic acid-containing oxidizing composition NIPPON PEROXIDE CO LTD (JP) 1999-02-03 EP claimed
EP-0522965-B1 Oral composition to reduce or eliminate bad breath and process of oral hygiene for eliminating bad breath OREAL (FR) 1996-03-06 EP claimed
US-5451346-A Fragrant peracetic acid-containing oxidizing composition INABATA KORYO CO., LTD. (JP) 1995-09-19 US claimed
EP-0596493-A1 Fragrant peracetic acid-containing oxidizing composition NIPPON PEROXIDE CO., LTD. (JP) 1994-05-11 EP claimed
US-4801446-A Use of methyl-isoeugenol, n-dodecanol, 1-(2-butenoyl)-2,6,6-trimethyl-1,3-cyclohexadiene and mixtures of same as insect attractants INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1989-01-31 US claimed
EP-0025638-B1 PROCESS FOR THE PRODUCTION OF 1-CROTONOYL-2,6,6-TRIMETHYLCYCLOHEXA-1,3-DIENE AND ESTERS OF ALKYNYLCYCLOHEXANE DERIVATIVES AS INTERMEDIATES THEREFOR PFW (NEDERLAND) B.V. (NL) 1983-05-11 EP claimed
US-4336401-A Process for the preparation of damascenone HERCULES INCORPORATED (US) 1982-06-22 US claimed
US-3959508-A Flavoring compositions containing mixture of 2,2,6-trimethyl-1-cyclohexen-1-ylacetaldehyde and 2,6,6-trimethyl-1-crotonyl-1,3-cyclohexadiene INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 1976-05-25 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260068882-A1 ARTHROPOD CONTROLLING COMPOSITION CNOT9, MSL1, MT-CO2 MAOA 2656/4885MAOB 3336/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 MAOA 638/4885MAOB 670/4885
US-20250034074-A1 PROCESS FOR PREPARING A CYCLIC DIENE DHPS, FDFT1, CYP17A1 MAOA 780/4885MAOB 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.